Literature DB >> 31257598

Monoclonal gammopathy-associated thrombotic microangiopathy.

Jennifer C Yui1, Daniel Garceau2, Kenar D Jhaveri3, Rimda Wanchoo3, Vanesa Bijol4, Ilya Glezerman5, Hani Hassoun6, Angela Dispenzieri7, Stephen J Russell7, Nelson Leung7,8.   

Abstract

Entities:  

Year:  2019        PMID： 31257598     DOI： 10.1002/ajh.25569

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  7 in total

1.  Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.

Authors:  Zi-Hao Yong; Xiao-Juan Yu; Jing-Xia Liu; Fu-de Zhou; Su-Xia Wang; Ming-Hui Zhao
Journal:  Clin J Am Soc Nephrol       Date:  2022-02-24       Impact factor: 8.237

2.  Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal Gammopathy.

Authors:  Nattawat Klomjit; Nelson Leung; Fernando Fervenza; Sanjeev Sethi; Ladan Zand
Journal:  J Am Soc Nephrol       Date:  2020-08-03       Impact factor: 10.121

3.  Bortezomib-induced glomerular microangiopathy complicated with monoclonal immunoglobulin deposition disease.

Authors:  Shinichi Mizuno; Chigusa Kitayama; Satoru Sanada; Toshinobu Sato
Journal:  CEN Case Rep       Date:  2021-04-28

Review 4.  Thrombotic Microangiopathy, an Unusual Form of Monoclonal Gammopathy of Renal Significance: Report of 3 Cases and Literature Review.

Authors:  Edward J Filippone; Eric D Newman; Li Li; Rakesh Gulati; John L Farber
Journal:  Front Immunol       Date:  2021-11-10       Impact factor: 7.561

5.  Scleroderma Renal Crisis Associated With Microangiopathic Hemolytic Anemia in a Patient With Seronegative Scleroderma and Monoclonal Gammopathy.

Authors:  Mark Riley; Paul Der Mesropian; Ana Maheshwari; Mustafa Erdem Arslan; Parth Visrodia; Loay Salman; Ruben Peredo-Wende; Llewellyn Foulke; Krishnakumar Hongalgi
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

6.  Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder.

Authors:  Guangyan Nie; Lianqin Sun; Chengning Zhang; Yanggang Yuan; Huijuan Mao; Zhen Wang; Jianyong Li; Suyan Duan; Changying Xing; Bo Zhang
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

Review 7.  Monoclonal Gammopathy of Undetermined Significance (MGUS)-Not So Asymptomatic after All.

Authors:  Oliver C Lomas; Tarek H Mouhieddine; Sabrin Tahri; Irene M Ghobrial
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.